Moderna said on Tuesday that the Food and Drug Administration (FDA) has refused to review its application for an mRNA flu vaccine, with the company claiming this decision is inconsistent with previous communications from the agency. In a press release Tuesday, Moderna said the FDA’s Center for Biologics Evaluation and Research (CBER) told the company…
